TABLE 3.
No. Patients | Doses of Ipilimumab | Response Duration | |
---|---|---|---|
Cohort A | 21 | ||
PR | 1 | 5 | 18 mo |
CR | 0 | — | — |
Cohort B | |||
Previous IL2 | 26 | ||
PR | 2 | 4, 4 | 7, 8 mo |
CR | 0 | — | — |
No previous IL2 | 14 | ||
PR | 3 | 3, 6, 4 | 12, 17, 21 mo |
CR | 0 | — | — |
CR indicates complete response; PR partial response.